XML 19 R5.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2023 $ 10,921 $ 170,620,641 $ (144,500,615) $ 26,130,947
Balance (in shares) at Dec. 31, 2023 33,094,521      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense $ 0 1,630,011 0 1,630,011
Issuances of common stock from the Sales Agreement, net $ 1,131 19,493,342 0 19,494,473
Issuances of common stock from the Sales Agreement, net (in shares) 3,428,681      
Issuances of common stock, from exercise of stock options $ 52 531,039 0 531,091
Issuances of common stock, from exercise of stock options (in shares) 156,073      
Net loss $ 0 0 (10,603,477) (10,603,477)
Balance at Mar. 31, 2024 $ 12,104 192,275,033 (155,104,092) 37,183,045
Balance (in shares) at Mar. 31, 2024 36,679,275      
Balance at Dec. 31, 2023 $ 10,921 170,620,641 (144,500,615) 26,130,947
Balance (in shares) at Dec. 31, 2023 33,094,521      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss       (18,931,374)
Balance at Jun. 30, 2024 $ 12,137 194,337,722 (163,431,989) 30,917,870
Balance (in shares) at Jun. 30, 2024 36,779,275      
Balance at Dec. 31, 2023 $ 10,921 170,620,641 (144,500,615) 26,130,947
Balance (in shares) at Dec. 31, 2023 33,094,521      
Balance at Dec. 31, 2024 $ 12,536 201,103,311 (182,110,999) 19,004,848
Balance (in shares) at Dec. 31, 2024 37,987,380      
Balance at Mar. 31, 2024 $ 12,104 192,275,033 (155,104,092) 37,183,045
Balance (in shares) at Mar. 31, 2024 36,679,275      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense $ 0 1,795,722 0 1,795,722
Issuance of common stock for consulting agreement $ 33 266,967 0 267,000
Issuance of common stock for consulting agreement (in shares) 100,000      
Net loss $ 0 0 (8,327,897) (8,327,897)
Balance at Jun. 30, 2024 $ 12,137 194,337,722 (163,431,989) 30,917,870
Balance (in shares) at Jun. 30, 2024 36,779,275      
Balance at Dec. 31, 2024 $ 12,536 201,103,311 (182,110,999) 19,004,848
Balance (in shares) at Dec. 31, 2024 37,987,380      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense $ 0 1,253,882 0 1,253,882
Issuance of common stock for consulting agreement $ 50 203,451 0 203,501
Issuance of common stock for consulting agreement (in shares) 150,000      
Issuances of common stock from the Sales Agreement, net $ 68 306,047 0 306,115
Issuances of common stock from the Sales Agreement, net (in shares) 205,350      
Issuances of common stock, net of issuance costs $ 2,111 6,919,908 0 6,922,019
Issuances of common stock, net of issuance costs (in shares) 6,396,787      
Issuance of pre-funded warrants $ 0 1,009,969 0 1,009,969
Issuance of warrants 0 2,150,771 0 2,150,771
Exercise of pre-funded warrants $ 233 (162) 0 71
Exercise of pre-funded warrants (in shares) 706,334      
Net loss $ 0 0 (8,488,967) (8,488,967)
Balance at Mar. 31, 2025 $ 14,998 212,947,177 (190,599,966) 22,362,209
Balance (in shares) at Mar. 31, 2025 45,445,851      
Balance at Dec. 31, 2024 $ 12,536 201,103,311 (182,110,999) 19,004,848
Balance (in shares) at Dec. 31, 2024 37,987,380      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss       (17,923,175)
Balance at Jun. 30, 2025 $ 15,390 215,978,568 (200,034,174) 15,959,784
Balance (in shares) at Jun. 30, 2025 46,633,362      
Balance at Mar. 31, 2025 $ 14,998 212,947,177 (190,599,966) 22,362,209
Balance (in shares) at Mar. 31, 2025 45,445,851      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense $ 0 448,029 0 448,029
Issuances of common stock from the Sales Agreement, net $ 317 1,460,325 0 1,460,642
Issuances of common stock from the Sales Agreement, net (in shares) 960,511      
Issuances of common stock, net of issuance costs $ 0 50,000 0 50,000
Issuances of common stock, net of issuance costs (in shares) 0      
Issuance of warrants $ 0 1,073,089 0 1,073,089
Exercise of pre-funded warrants $ 75 (52) 0 23
Exercise of pre-funded warrants (in shares) 227,000      
Net loss $ 0 0 (9,434,208) (9,434,208)
Balance at Jun. 30, 2025 $ 15,390 $ 215,978,568 $ (200,034,174) $ 15,959,784
Balance (in shares) at Jun. 30, 2025 46,633,362